Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oak Street Health Inc (NY: OSH )

39.00 UNCHANGED
Last Price Updated: 7:00 PM EDT, May 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 39.00
Bid (Size) 38.99 (50)
Ask (Size) 39.98 (50)
Prev. Close 39.00
Today's Range 39.00 - 39.00
52wk Range 14.48 - 38.99
Shares Outstanding 241,074,229
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health
 
Via Benzinga
Oak Street Health Inc. (NYSE: OSH) Records 52-Week High Wednesday Morning
Via Investor Brand Network

Performance

YTD
+83.27%
+83.27%
1 Month
N/A
N/A
3 Month
+9.89%
+9.89%
6 Month
+83.27%
+83.27%
1 Year
+117.03%
+117.03%

More News

Read More
1 Unstoppable Dividend Stock Down 30% to Buy on the Dip
Via The Motley Fool
OAK STREET HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oak Street Health, Inc. - OSH
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Univar Solutions Inc. (NYSE - UNVR), Oak Street Health (NYSE – OSH), Seagen Inc. (Nasdaq - SGEN), U.S. Xpress Enterprises, Inc. (NYSE – USX)
From Brodsky & Smith LLC
Via GlobeNewswire
Top 5 Health Care Stocks That May Collapse
Via Benzinga
Oak Street Health Inc. (NYSE: OSH) Sets New 52-Week High in Thursday Session
Via Investor Brand Network
Oak Street Health Announces Cancellation of its 2023 Annual Meeting of Stockholders
From Oak Street Health
Via Business Wire
This Boring Business Could Be a Secret Weapon to Beat the Market
Via The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Oak Street Health (NYSE – OSH), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL)
From Brodsky & Smith LLC
Via GlobeNewswire
What 10 Analyst Ratings Have To Say About Oak Street Health
Via Benzinga
OakWell Launches to Provide High-Quality Primary Care Directly to Kidney Patients in Dialysis Centers
From  Oak Street Health
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Via Benzinga
Oak Street Health Inc. (NYSE: OSH) Sets New 52-Week High in Monday Session
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
Via Benzinga
3 Reliable Dividend Stocks to Buy and Hold for Decades of Passive Income
Via The Motley Fool
Could CVS Health Help You Become a Millionaire?
Via The Motley Fool
Is CVS Health a Good Dividend Stock to Buy Now?
Via The Motley Fool
Oak Street Health Reports Full Year 2022 Results
From Oak Street Health
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
Breaking Down the Latest Wall Street News: AI to Pizza
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
Via Benzinga
Which Healthcare Stock Is a Better Pick in 2023?
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NUVASIVE (Nasdaq – NUVA), Oak Street Health (NYSE – OSH), Argo Group International Holdings, Ltd. (NYSE - ARGO), Cardiovascular Systems, Inc. (Nasdaq – CSII)
From Brodsky & Smith LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.